Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
|
Product:
Component 1:
Active Ingredients:
Dosage Form:
Component 2:
Active Ingredients:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Actair 100 IR & 300 IR Initiation treatment sublingual tablets
Dermatophagoides farinae allergen extract 50IR
Dermatophagoides pteronyssinus allergen extract 50IR
Sublingual tablet
Dermatophagoides farinae allergen extract 150IR
Dermatophagoides pteronyssinus allergen extract 150IR
Sublingual tablet
Ebos Group Limited
Cenexi SAS, Paris, France
|
|
Product:
Active Ingredients:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Actair 300 IR Continuation treatment sublingual tablets
Dermatophagoides farinae allergen extract 150IR
Dermatophagoides pteronyssinus allergen extract 150IR
Sublingual tablet
Ebos Group Limited
Cenexi SAS, Paris, France
|
Dated this 22nd day of September 2017.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz